Global Structural Heart Disease Intervention Devices Supply, Demand and Key Producers, 2023-2029

Global Structural Heart Disease Intervention Devices Supply, Demand and Key Producers, 2023-2029

The global Structural Heart Disease Intervention Devices market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Structural heart disease intervention devices are medical devices used to treat heart diseases by repairing or replacing diseased or defective heart tissues or structures through minimally invasive procedures. Common types of structural heart disease intervention devices include:



Atrial septal defect closure devices: used to treat congenital heart defects by inserting a device into the heart through a catheter and placing a closure device over the defect to prevent blood from flowing from the left atrium to the right atrium.



Mitral valve repair devices: used to treat mitral valve regurgitation or prolapse by inserting a device into the heart through a catheter and placing a repair device over the damaged or prolapsed valve.



Transcatheter aortic valve replacement devices: used to treat aortic valve stenosis or regurgitation by inserting an artificial valve into the heart through a catheter and replacing the damaged aortic valve.



Cerebral aneurysm coiling devices: used to treat cerebral aneurysms or narrowing of the blood vessels in the brain by inserting a coil into the blood vessel through a catheter to strengthen the blood vessel and prevent blood from leaking out.



These structural heart disease intervention devices have been widely used in clinical practice and have achieved good treatment results, significantly improving the cardiovascular function of patients and enhancing their quality of life.

This report studies the global Structural Heart Disease Intervention Devices production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Structural Heart Disease Intervention Devices, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Structural Heart Disease Intervention Devices that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Structural Heart Disease Intervention Devices total production and demand, 2018-2029, (K Units)

Global Structural Heart Disease Intervention Devices total production value, 2018-2029, (USD Million)

Global Structural Heart Disease Intervention Devices production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Structural Heart Disease Intervention Devices consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Structural Heart Disease Intervention Devices domestic production, consumption, key domestic manufacturers and share

Global Structural Heart Disease Intervention Devices production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Structural Heart Disease Intervention Devices production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Structural Heart Disease Intervention Devices production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Structural Heart Disease Intervention Devices market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Structural Heart, Philips, Japen Lifeline, Neovasc, Append Medical, Transverse Medical, Cardiomech, Thubrikar Aortic Valve Inc and Boston Scientific, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Structural Heart Disease Intervention Devices market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Structural Heart Disease Intervention Devices Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Structural Heart Disease Intervention Devices Market, Segmentation by Type
Atrial Interventional Class
Cardiovascular Intervention

Global Structural Heart Disease Intervention Devices Market, Segmentation by Application
Congenital Heart Disease Treatment
Valvular Heart Disease Treatment
Cardiomyopathy Treatment
Aneurysm and Arterial Valve Disease Treatment
Others

Companies Profiled:
Abbott Structural Heart
Philips
Japen Lifeline
Neovasc
Append Medical
Transverse Medical
Cardiomech
Thubrikar Aortic Valve Inc
Boston Scientific
Edwards Lifesciences Corporation
Biomerics
LivaNova PLC

Key Questions Answered

1. How big is the global Structural Heart Disease Intervention Devices market?

2. What is the demand of the global Structural Heart Disease Intervention Devices market?

3. What is the year over year growth of the global Structural Heart Disease Intervention Devices market?

4. What is the production and production value of the global Structural Heart Disease Intervention Devices market?

5. Who are the key producers in the global Structural Heart Disease Intervention Devices market?

6. What are the growth factors driving the market demand?